Fig. 11From: Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysisPooled HCV Ab prevalence among PWID by recruitment setting. a Before 2005; b during and after 2005Back to article page